Bristlecone Advisors LLC Maintains Position in Danaher Corporation (DHR)
Bristlecone Advisors LLC continued to hold its stake in Danaher Corporation (NYSE:DHR) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,476 shares of the conglomerate’s stock at the end of the second quarter. Bristlecone Advisors LLC’s holdings in Danaher Corporation were worth $293,000 as of its most recent filing with the SEC.
A number of other large investors have also added to or reduced their stakes in DHR. Peddock Capital Advisors LLC increased its stake in Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock valued at $105,000 after buying an additional 181 shares in the last quarter. Proficio Capital Partners LLC increased its stake in Danaher Corporation by 92.3% in the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after buying an additional 598 shares in the last quarter. ClariVest Asset Management LLC acquired a new stake in Danaher Corporation during the first quarter valued at about $157,000. Baystate Wealth Management LLC increased its stake in Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock valued at $163,000 after buying an additional 60 shares in the last quarter. Finally, Cornerstone Advisors Inc. increased its stake in Danaher Corporation by 62.0% in the second quarter. Cornerstone Advisors Inc. now owns 2,111 shares of the conglomerate’s stock valued at $178,000 after buying an additional 808 shares in the last quarter. Institutional investors own 75.74% of the company’s stock.
Shares of Danaher Corporation (DHR) opened at 81.99 on Wednesday. The company has a 50-day moving average of $82.08 and a 200 day moving average of $84.16. The firm has a market capitalization of $56.96 billion, a PE ratio of 26.17 and a beta of 1.03. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01.
Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The firm had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. During the same period in the prior year, the firm posted $0.90 EPS. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, analysts predict that Danaher Corporation will post $3.95 EPS for the current year.
COPYRIGHT VIOLATION WARNING: “Bristlecone Advisors LLC Maintains Position in Danaher Corporation (DHR)” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/30/bristlecone-advisors-llc-maintains-position-in-danaher-corporation-dhr.html.
Several research firms have issued reports on DHR. Wells Fargo & Company reiterated a “market perform” rating on shares of Danaher Corporation in a research note on Saturday, July 22nd. Jefferies Group LLC reiterated a “buy” rating and set a $95.00 price objective on shares of Danaher Corporation in a research note on Friday, August 4th. BidaskClub downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, July 25th. Credit Suisse Group reiterated a “buy” rating and set a $93.00 price objective on shares of Danaher Corporation in a research note on Wednesday, May 24th. Finally, Janney Montgomery Scott downgraded shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 7th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $91.76.
In other Danaher Corporation news, insider William King sold 7,458 shares of the company’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $82.97, for a total value of $618,790.26. Following the transaction, the insider now directly owns 18,245 shares of the company’s stock, valued at approximately $1,513,787.65. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Linda P. Hefner sold 10,578 shares of the company’s stock in a transaction on Friday, July 21st. The shares were sold at an average price of $83.03, for a total value of $878,291.34. Following the completion of the transaction, the director now directly owns 42,151 shares in the company, valued at $3,499,797.53. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 27,808 shares of company stock worth $2,296,236. Insiders own 12.20% of the company’s stock.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.